Impact Factor
3.24
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.13
803 total citations
h5-index
32
h5 depth signal
Cited share
60.0%
228 of 380
Total citations
803
Citation footprint
Metric signal
2.36
External metric anchor
Self-citation
6.5%
52 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Brazil
1,378
China
137
Turkey
123
Spain
107
Portugal
72
Citing Fields of Research
Dermatology
1,239
Auto-Inflammatory Disorders
297
Allergies
297
Oncology
249
Musculoskeletal Disorders
164
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,414
Articles tracked across the journal lifetime
Indexed publication set
380
228 cited publications
Last 12 months
222
20.2 publications/month
Open access share
100.0%
222 OA publications in the last year
Leading citing country
Brazil
1,378 citing publications
Leading citing field
Dermatology
1,239 citing publications
Latest tracked publication
28 September 2026
10 recent records available
Coverage & Indexing History
v41n2, Apr./Jun. 1966- v46n1, Jan./Mar. 1971; v83n1, Jan./Feb. 2008-
v41n2, Apr./Jun. 1966- v46n1, Jan./Mar. 1971; v83n1, Jan./Feb. 2008-
Active Coverage
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Dermatology
Issuing & Sponsoring Bodies
Contributor
Sociedade Brasileira de Dermatologia e Sifilografia
Contributor
Sociedade Brasileira de Dermatologia
Broad Categories
Dermatology
Musculoskeletal Disorders
Epithelial Barriers
Allergies
Auto-Inflammatory Disorders
MeSH Descriptors
Dermatology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.abd.2026.501462
Open DOI
RETRACTION to “What is your diagnosis? CLOVES syndrome” An Bras Dermatol. 2016;91(3):378-80
02
DOI 10.1016/j.abd.2026.501443
Open DOI
Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis
03
DOI 10.1016/j.abd.2026.501461
Open DOI
Randomized, double-blind pilot study on botulinum toxin type A in the treatment of axillary hidradenitis suppurativa
04
05
06
DOI 10.1016/j.abd.2026.501453
Open DOI
Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
07
DOI 10.1016/j.abd.2026.501460
Open DOI
Beyond stigma: integrating social and diagnostic determinants of delayed leprosy detection
08
DOI 10.1016/j.abd.2026.501458
Open DOI
The stigma-induced diagnostic gap: a critical barrier to leprosy elimination
09
DOI 10.1016/j.abd.2026.501450
Open DOI
Cutaneous metastasis of breast carcinoma with an angiokeratoma-like pattern: a dermoscopic diagnostic pitfall
10
DOI 10.1016/j.abd.2026.501449
Open DOI
Clinical practice guideline for psoriasis management in Latin America
Bibliographical & Catalog Notes
Also issued online.
In Portuguese; summaries in English and Portuguese, -2011; in English, summaries and table of contents in English and Portuguese, 2012- . Online version available in Portuguese with English abstracts, 2002-2008; English and Portuguese, 2009- . Search interfaces available in Portuguese, English and Spanish.
Issued by the Sociedade Brasileira de Dermatologia e Sifilografia, 1961-1964; Sociedade Brasileira de Dermatologia, 1965- .
20111107 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper